Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human cytomegalovirus immediate-early protein 2 (IE2) is a multifunctional viral transcription factor encoded by the UL122 locus of the HCMV genome. It is expressed early after infection as three major isoforms (p86, p60, p40). IE2 directly binds viral DNA, activates and represses viral gene transcription—including autoregulation of the immediate-early promoter—and is essential for progression of the viral lytic cycle. IE2 orchestrates the formation of viral replication compartments in the host cell nucleus and interacts dynamically with host transcription factors (TBP, TFIIB, and chromatin modifiers). Beyond its viral regulatory activities, IE2 modulates host cell signaling, promotes G1/S cell cycle transition, and arrests S phase progression, preventing host DNA replication while favoring viral replication. IE2 also antagonizes host immune signaling by downregulating interferon-β and inflammatory chemokine responses. These diverse regulatory actions make IE2 a key determinant of HCMV infection, pathogenesis, and persistence.
Not directly applicable; hypothetical or experimental drugs would act by: - Inhibiting IE2-DNA binding - Blocking IE2-mediated transcriptional regulation - Interfering with protein-protein interactions between IE2 and host or viral factors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human cytomegalovirus immediate-early protein 2 (IE2).